Evidence-based data about prevalence and risk of malignancy of thyroid incidentalomas detected by different PET radiopharmaceuticals.

BACKGROUND To date, several meta-analyses and systematic reviews have reported data about prevalence and risk of malignancy of thyroid incidentalomas detected by different PET radiopharmaceuticals. OBJECTIVE This article aims to summarize the published evidence-based data about prevalence and risk of malignancy of thyroid incidentalomas detected by different PET radiopharmaceuticals. METHODS A comprehensive computer literature search of systematic reviews and meta-analyses published up to July 2019 in PubMed/MEDLINE and Cochrane library databases regarding the prevalence and risk of malignancy of thyroid incidentalomas detected by different PET radiopharmaceuticals was carried out. RESULTS We have summarized the data about prevalence and risk of malignancy of thyroid incidentalomas detected by different PET radiopharmaceuticals (fluorine-18 fluorodeoxyglucose, radiolabelled choline and prostate-specific membrane antigen) taking into account 8 evidence-based articles. CONCLUSION Evidence-based data demonstrated that thyroid incidentalomas detected by different PET radiopharmaceuticals are not infrequent and their risk of malignancy is not negligible, in particular if focal pattern is evident at PET, thus requiring further clinical and instrumental evaluation.

[1]  L. Giovanella,et al.  68Ga-PSMA PET thyroid incidentalomas , 2019, Hormones.

[2]  John O. Prior,et al.  Radiolabelled choline versus PSMA PET/CT in prostate cancer restaging: a meta-analysis. , 2019, American journal of nuclear medicine and molecular imaging.

[3]  L. Giovanella,et al.  F18-choline/C11-choline PET/CT thyroid incidentalomas , 2019, Endocrine.

[4]  L. Giovanella,et al.  Prevalence and clinical significance of focal incidental 18F-FDG uptake in different organs: an evidence-based summary , 2017, Clinical and Translational Imaging.

[5]  R. Hicks,et al.  18F-FDG–Avid Thyroid Incidentalomas: The Importance of Contextual Interpretation , 2017, The Journal of Nuclear Medicine.

[6]  L. Cozzi,et al.  [18F]FDG-PET/CT texture analysis in thyroid incidentalomas: preliminary results , 2017, European Journal of Hybrid Imaging.

[7]  G. Treglia,et al.  Systematic reviews and meta-analyses of diagnostic studies: a practical guideline , 2017, Clinical and Translational Imaging.

[8]  Dimitrios G Goulis,et al.  Thyroid nodules: Α guide to assessment, treatment and follow-up. , 2017, Maturitas.

[9]  P. Herscovitch,et al.  The Rate and Clinical Significance of Incidental Thyroid Uptake as Detected by Gallium-68 DOTATATE Positron Emission Tomography/Computed Tomography. , 2016, Thyroid : official journal of the American Thyroid Association.

[10]  Michael K. Gupta,et al.  The Proportion of Malignancy in Incidental Thyroid Lesions on 18-FDG PET Study , 2014, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

[11]  A. Del Sole,et al.  Diagnostic performance of PET/CT with tracers other than F-18-FDG in oncology: an evidence-based review , 2014, Clinical and Translational Oncology.

[12]  N. Qu,et al.  Risk of malignancy in focal thyroid lesions identified by 18F-fluorodeoxyglucose positron emission tomography or positron emission tomography/computed tomography: evidence from a large series of studies , 2014, Tumor Biology.

[13]  G. Treglia,et al.  Meta-analyses and systematic reviews on PET and PET/CT in oncology: the state of the art , 2013, Clinical and Translational Imaging.

[14]  A. Piccardo,et al.  Diagnostic and clinical significance of F-18-FDG-PET/CT thyroid incidentalomas. , 2012, The Journal of clinical endocrinology and metabolism.

[15]  L. Hegedüs,et al.  Risk of malignancy in thyroid incidentalomas detected by 18F-fluorodeoxyglucose positron emission tomography: a systematic review. , 2012, Thyroid : official journal of the American Thyroid Association.

[16]  R. Cardarelli,et al.  Systematic review: prevalence of malignant incidental thyroid nodules identified on fluorine-18 fluorodeoxyglucose positron emission tomography , 2009, Nuclear medicine communications.

[17]  L. Hegedüs,et al.  The Thyroid Nodule , 2004 .

[18]  L. Hegedüs,et al.  Management of simple nodular goiter: current status and future perspectives. , 2003, Endocrine reviews.

[19]  L. Królicki,et al.  How often do we see incidental 68Ga-DOTATATE thyroid uptake in PET/CT in patients with neuroendocrine tumours? , 2015, Endokrynologia Polska.

[20]  L. Ceriani,et al.  Focal thyroid incidental uptake detected by 18F-fluorodeoxyglucose positron emission tomography , 2013, Nuklearmedizin.

[21]  C. McHenry,et al.  Thyroid incidentaloma. , 2012, Best practice & research. Clinical endocrinology & metabolism.